Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, emerging biomarkers and personalized treatment strategies. We begin with an editorial by Isabela Wen-Chi Chang […]

Masanori Terashima, ASCO GI 2021: the MONA LISA Study

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Feb 12th 2021

We were delighted to talk to Masanori Terashima about the advantages of robot-assisted gastrectomy for clinical stage T1-2N0-2 gastric cancer patients (Clinical Trial Identifier: UMIN000039825).

The abstract ‘Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-2N0-2 gastric cancer patients: Japan Clinical Oncology Group study JCOG1907 (MONA LISA study)’ (ABSTRACT NUMBER: TPS254) was presented at the virtual ASCO Gastrointestinal Cancers Symposium 2021, 15-17 January, 2021.

Questions

  1. Could you give us a brief overview of the postoperative complications that may occur after surgery in gastric cancer, and their prognostic significance? (0:14)
  2. What are the advantages and limitations of laparoscopic gastrectomy compared with open gastrectomy? (0:55)
  3. Could you tell us a little about robot-assisted gastrectomy and its clinical development to date? (2:02)
  4. What are the aims and design of the JCOG1907 study? (3:05)
  5. What does the future hold for robot-assisted surgical procedures in oncology? (3:52)

Disclosures: Masanori Terashima has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media.

Filmed as a highlight of ASCO GI 2021 (Virtual).

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup